Header Logo

Connection

Michael Rudolph to Antineoplastic Agents, Hormonal

Back to Details
This is a "connection" page, showing publications Michael Rudolph has written about Antineoplastic Agents, Hormonal.
Michael Rudolph
Connection Strength
0.060
Antineoplastic Agents, Hormonal
  1. Lipid metabolic reprogramming drives triglyceride storage and variable sensitivity to FASN inhibition in endocrine-resistant breast cancer cells. Breast Cancer Res. 2025 Mar 07; 27(1):32.
    View in: PubMed
    Score: 0.060
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.